Nephrology and Renal Disease

Nephrology and Renal Disease

The Medpace Difference for Renal Disease and Nephrology Studies

Medpace conducts trials in renally-impaired patients, including patients currently undergoing dialysis, and in patients suffering from other chronic and rare kidney diseases.

Sponsors conducting clinical research in nephrology and renal diseases benefit from:

  • In-house board-certified nephrologist with more than 30 years of experience in clinical drug development, responsible for leading several drugs from early phase development through product launch
  • Global experience conducting Phase I-IV renal disease clinical trials spanning adult and pediatric populations
  • Strong relationships with successful, experienced investigative sites which regularly participate and successfully enroll nephrology studies
  • A seasoned clinical operations staff with specific experience in conducting renal disease trials
  • Thorough understanding of the complex metabolic conditions that cause CKD, as well as the medical complications experienced by patients with CKD and ESRD (end-stage renal disease)
  • Cross-over medical expertise in related therapeutic areas including metabolic, cardiovascular, and autoimmune
  • Specialized expertise in rare disease and orphan indications
  • Integrated core imaging, ECG and central laboratory services